GL1X · GenesisL1 explorer

Research workbench

Second bromodomain from leishmania donovani LDBPK.091320 complexed with bromosporine

Analyse Second bromodomain from leishmania donovani LDBPK.091320 complexed with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5TCK
Type
protein
Length
276 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Uncharacterized protein
UniProt
E9BA17
Ligands
BMF, SX
Pockets
1 · best druggability 0.82

Structure

x-ray diffraction · 2 distinct chains · 61% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AUncharacterized proteinprotein13961% helix, 0% strandE9BA17
BUncharacterized proteinprotein13761% helix, 0% strandE9BA17

Ligands and binding sites

  • BMF · Bromosporine · ligand · 2 copies · chains A, B
  • SX · Sulfur oxide · ligand · 2 copies · chains A, B
  • BME · Beta-mercaptoethanol · additive · 2 copies · chains A, B
  • EDO · 1,2-ethanediol · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16940.820.8659BMF, BME, SX

Interfaces

1 interface between chains.

  • A–B · 742 Ų buried · 5 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 covalent (additive adduct, covalent ligand).

Compared structures

  • 5TCK · Second Bromodomain from Leishmania donovani LdBPK.091320 complexed with Bromosporine · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.